The oncogenic effects of EGFR include initiation of DNA synthesis
Immunogen: A synthesized peptide derived from human CARD12
MCM3 Polyclonal Antibody-BS6111
showing cytoplasmic and nuclear staining
EIF5A Polyclonal Antibody
Chemokine Receptor D6 (S383) Polyclonal Antibody-BS2588 HeLa Transfection The oncogenic effects of EGFRChemokine Receptor D6 (S383) Polyclonal Antibody Sizes: 50l, 100l Catalogue Numbers: BS2588 50, BS2588 100 Product: Rabbit IgG, 1mg ml in PBS with 0. 02% sodium azide, 50% glycerol, pH7. 2 Swiss Prot: O00590 Host: Rabbit Reactivity: Human, Mouse, Rat Applications: IHC, IF All Applications: IHC: 1: 50~1: 200 IF: 1: 50~1: 200 Background: Chemokine Receptor D6 (also designated Chemokine binding protein 2, C C chemokine receptor D6, CCR 9, CCR 10, and